Onset timing of statin‐induced musculoskeletal adverse events and concomitant drug‐associated shift in onset timing of MAEs

Documenti analoghi

• Identification and Characteristics of Time-Related Shifts in Suicide-Related Event Frequency During Smoking Cessation Treatment with Varenicline
  di: Akimoto, Hayato, et al.
  Pubblicazione: (2017)
• Assessment of the Risk of Suicide-Related Events Induced by Concomitant Use of Antidepressants in Cases of Smoking Cessation Treatment with Varenicline and Assessment of Latent Risk by the Use of Varenicline
  di: Akimoto, Hayato, et al.
  Pubblicazione: (2016)
• Discrepancies between patients’ and pharmacists’ perceptions of the role of community pharmacists as advisors on the use of pharmaceuticals in Japan: A comparison prior to and following revision of the Pharmacists’ Act
  di: Oshima, Shinji, et al.
  Pubblicazione: (2019)
• Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
  di: Negishi, Akio, et al.
  Pubblicazione: (2020)
• Absorption Kinetics of Subcutaneously Administered Ceftazidime in Hypoperfused Guinea Pigs
  di: Ebihara, Tsuyoshi, et al.
  Pubblicazione: (2014)